Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness — Stella

Recruiting

Back to Normal Weight trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

University Clinic Tubingen, Department of Internal Medicine IV, Tübingen

Key details

Sponsor

University Hospital Tuebingen

Enrollment target

~60 participants

Started

July 2024

Primary completion

July 2027

Age range

18 Years – 70 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov